Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart Failure
Top Cited Papers
- 1 August 2007
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 50 (8) , 768-777
- https://doi.org/10.1016/j.jacc.2007.04.064
Abstract
No abstract availableKeywords
Funding Information
- Sigma-Tau Pharmaceuticals
- GlaxoSmithKline
- Merck
- National Institutes of Health
- Abbott Laboratories
- Medtronic
This publication has 24 references indexed in Scilit:
- Effects of Digoxin on Morbidity and Mortality in Diastolic Heart FailureCirculation, 2006
- ACC/AHA Clinical Performance Measures for Adults With Chronic Heart FailureJournal of the American College of Cardiology, 2005
- American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular careJournal of the American College of Cardiology, 2005
- Heart failure in patients with preserved and deteriorated left ventricular ejection fractionHeart, 2005
- Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure SurveyEuropean Heart Journal, 2004
- Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and designAmerican Heart Journal, 2004
- Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failureAmerican Heart Journal, 2003
- Incident cases of heart failure in a community cohort: importance and outcomes of patients with preserved systolic functionAmerican Heart Journal, 2003
- Outcomes in heart failure patients with preserved ejection fractionJournal of the American College of Cardiology, 2003
- Clinical presentation, hospital length of stay, and readmission rate in patients with heart failure with preserved and decreased left ventricular systolic functionClinical Cardiology, 2002